Skip to content
Home›Awards›Novartis Pharmaceuticals Corporation
$

Federal Contract Award

Novartis Pharmaceuticals Corporation

Department of Veterans Affairs · September 28, 2026 · FY2026

36C26126F0168Set-aside not reportedNAICS 325412

Obligated

$1,200,299

Contract details

Award ID
CONT_AWD_36C26126F0168_3600_36F79720D0180_3600
PIID
36C26126F0168
Period of performance
April 1, 2026 → September 30, 2026
Place of performance
MATHER, CA, USA
Set-aside
Not reported
Pricing type
FIRM FIXED PRICE
PSC
6505 — DRUGS AND BIOLOGICALS
NAICS
325412 — PHARMACEUTICAL PREPARATION MANUFACTURING

Scope

PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML

Parent vehicle (IDV)

Novartis Sanierungsstiftung

UEI YE3YG1FDWMC5

This award was placed as a task/delivery order under a larger contract vehicle.

Recipient

Novartis Pharmaceuticals Corporation →
UEI
NG61ZA8TADW3
CAGE
04520
Parent
Novartis Sanierungsstiftung
Address
EAST HANOVER, NJ

Awarding agency

Department of Veterans Affairs →
Sub-agency
Department of Veterans Affairs
Office
261-NETWORK CONTRACT OFFICE 21 (36C261)
Funding agency
Department of Veterans Affairs
Funding office
261-NETWORK CONTRACT OFFICE 21 (36C261)

See every contract Novartis Pharmaceuticals Corporation has won

Full contracting history, year-over-year trends, subaward graph, and recompete alerts.

View Novartis Pharmaceuticals Corporation profile →